Agenda
Publication
  • ASN •
  • 6 November, 2025 •
  • •

Effect of Nanoencapsulated Sirolimus plus Pegadricase (NASP) on Kidney Outcomes: Results from the Phase 3 DISSOLVE Studies

Minesh Rajpal, Vibeke Strand, Rehan Azeem, Ben Peace, Bhavisha Desai, Richard J. Johnson

Available materials

Poster
Publication
  • ASN •
  • 6 November, 2025 •
  • •

Nanoencapsulated Sirolimus Plus Pegadricase (NASP) Reduces Gout Clinical Manifestations in Patients With Uncontrolled Gout (UG) and Stage 3 CKD

Nissreen Elfadawy, Puja Khanna, Rehan Azeem, Ben Peace, Bhavisha Desai, Yasir Qazi

Available materials

Poster
Publication
  • ASN •
  • 6 November, 2025 •
  • •

Management of Uncontrolled Gout Among Nephrology Professionals: Findings from a Medical Chart Audit

Hyon Choi, Nana Kragh, Amod Athavale, Bhavisha Desai, Amal Gulaid, Abiola Oladapo, Brittany Smith, Kenneth Saag

Available materials

Poster
Publication
  • ACR •
  • 28 October, 2025 •
  • •

Nanoencapsulated Sirolimus Plus Pegadricase Reduced Disease Burden in Patients With Uncontrolled Gout: Results From the Phase 3 DISSOLVE Trials

Puja Khanna, Amar Majjhoo, Rehan Azeem, Ben Peace, Bhavisha Desai, Vibeke Strand

Available materials

Oral Presentation
Sign up for alerts